Skip to main content
SpringerLink
Log in

The three ‘A’s of treating chronic prostatitis/chronic pelvic pain syndrome: antibacterials, α-adrenergic receptor antagonists and anti-inflammatory agents

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

References

  1. Murphy AB, Macejko A, Taylor A, et al. Chronic prostatitis: management strategies. Drugs 2009; 69(1): 71–84

    Article  PubMed  CAS  Google Scholar 

  2. Krieger JN, Nyberg Jr L, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999 Jul 21; 282(3): 236–7

    Article  PubMed  CAS  Google Scholar 

  3. McNaughton Collins M, MacDonald R, Wilt TJ. Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Ann Intern Med 2000 Sep 5; 133(5): 367–81

    Google Scholar 

  4. Nadler RB, Collins MM, Propert KJ, et al. Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome. Urology 2006 Feb; 67(2): 337–42

    Article  PubMed  Google Scholar 

  5. Hochreiter WW, Duncan JL, Schaeffer AJ. Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction. J Urol 2000 Jan; 163(1): 127–30

    Article  PubMed  CAS  Google Scholar 

  6. Potts J, Payne RE. Prostatitis: infection, neuromuscular disorder, or pain syndrome? Proper patient classification is key. Cleve Clin J Med 2007 May; 74Suppl. 3: S63–71

    Article  PubMed  Google Scholar 

  7. Nickel JC. Treatment of chronic prostatitis/chronic pelvic pain syndrome. Int J Antimicrob Agents 2008 Feb; 31Suppl. 1: S112–6

    Article  PubMed  CAS  Google Scholar 

  8. Nadler RB. Bladder training biofeedback and pelvic floor myalgia. Urology 2002 Dec; 60(6 Suppl.): 42–3; discussion 4

    Article  PubMed  Google Scholar 

  9. Lee SW, Liong ML, Yuen KH, et al. Adverse impact of sexual dysfunction in chronic prostatitis/chronic pelvic pain syndrome. Urology 2008 Jan; 71(1): 79–84

    Article  PubMed  Google Scholar 

  10. Walz J, Perrotte P, Hutterer G, et al. Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men. BJU Int 2007 Dec; 100(6): 1307–11

    Article  PubMed  Google Scholar 

  11. Nickel JC, Downey J, Johnston B, et al. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol 2001 May; 165(5): 1539–44

    Article  PubMed  CAS  Google Scholar 

  12. Nickel JC, Downey J, Clark J, et al. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology 2003 Oct; 62(4): 614–7

    Article  PubMed  Google Scholar 

  13. Alexander RB, Propert KJ, Schaeffer AJ, et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 2004 Oct 19; 141(8): 581–9

    PubMed  CAS  Google Scholar 

  14. Nickel J, Xiang J. Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis. J Urol 2008 Apr; 179(4): 1391–5

    Article  PubMed  Google Scholar 

  15. Litwin MS, McNaughton-Collins M, Fowler Jr FJ, et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 1999 Aug; 162(2): 369–75

    Article  PubMed  CAS  Google Scholar 

  16. Lee SW, Liong ML, Yuen KH, et al. Chronic prostatitis/chronic pelvic pain syndrome: role of alpha blocker therapy. Urol Int 2007; 78(2): 97–105

    Article  PubMed  CAS  Google Scholar 

  17. Ye ZQ, Lan RZ, Yang WM, et al. Tamsulosin treatment of chronic non-bacterial prostatitis. J Int Med Res 2008 Mar–Apr; 36(2): 244–52

    PubMed  CAS  Google Scholar 

  18. Tugcu V, Tasci AI, Fazlioglu A, et al. A placebo-controlled comparison of the efficiency of triple- and monotherapy in category IIIB chronic pelvic pain syndrome (CPPS). Eur Urol 2007 Apr; 51(4): 1113–7; discussion 8

    Article  PubMed  CAS  Google Scholar 

  19. Nickel JC. Opioids for chronic prostatitis and interstitial cystitis: lessons learned from the 11th World Congress on Pain. Urology 2006 Oct; 68(4): 697–701

    Article  PubMed  Google Scholar 

  20. Nickel JC, Downey J, Pontari MA, et al. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int 2004 May; 93(7): 991–5

    Article  PubMed  CAS  Google Scholar 

  21. Nickel JC, Forrest JB, Tomera K, et al. Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J Urol 2005 Apr; 173(4): 1252–5

    Article  PubMed  Google Scholar 

  22. Shoskes DA, Zeitlin SI, Shahed A, et al. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999 Dec; 54(6): 960–3

    Article  PubMed  CAS  Google Scholar 

  23. Rugendorff EW, Weidner W, Ebeling L, et al. Results of treatment with pollen extract (Cernilton N) in chronic prostatitis and prostatodynia. Br J Urol 1993 Apr; 71(4): 433–8

    Article  PubMed  CAS  Google Scholar 

  24. Kaplan SA, Volpe MA, Te AE. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J Urol 2004 Jan; 171(1): 284–8

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The three ‘A’s of treating chronic prostatitis/chronic pelvic pain syndrome: antibacterials, α-adrenergic receptor antagonists and anti-inflammatory agents. Drugs Ther. Perspect 25, 13–16 (2009). https://doi.org/10.2165/0042310-200925090-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/0042310-200925090-00004

Search

Navigation